Compare TSAT & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSAT | INMD |
|---|---|---|
| Founded | 1969 | 2008 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 697.5M | 805.0M |
| IPO Year | 2021 | 2018 |
| Metric | TSAT | INMD |
|---|---|---|
| Price | $40.30 | $14.14 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | ★ $65.70 | $16.17 |
| AVG Volume (30 Days) | 98.6K | ★ 373.1K |
| Earning Date | 11-03-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.30 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.01 | $12.72 |
| 52 Week High | $61.54 | $16.67 |
| Indicator | TSAT | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 38.28 |
| Support Level | $44.96 | $13.79 |
| Resistance Level | $46.56 | $14.18 |
| Average True Range (ATR) | 2.10 | 0.17 |
| MACD | -0.14 | 0.03 |
| Stochastic Oscillator | 47.98 | 35.80 |
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. The company has two operating segments: GEO services (GEO) segment that refers to the operation of the fleet of GEO satellite and LEO services (LEO) segment that refers to the deployment and operation of the Telesat Lightspeed constellation Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.